CXCR4 and breast cancer: CXCL12-γ mostly expressed by carcinoma-associated fibroblasts confer to CXCR4-positive breast cancer cells the ability to metastasize into BM through the expression of the receptor activator of NFκB ligand (RANKL) [21].